Frequency Exchange Corp

Frequency Exchange Corp has a debt-to-equity ratio of 0.75 and a current ratio of 1.75, indicating moderate leverage and acceptable short-term liquidity. However, the company reported negative operating cash flow of CAD -1.22 million and free cash flow of CAD -1.66 million, signaling cash burn and reliance on external financing. The negative return on equity (-2.63) and return on assets (-1.20) further highlight operational inefficiencies and poor capital utilization. The company's operating income of CAD -1.65 million and net loss of CAD -1.69 million contrast sharply with industry benchmarks for Industrial Machinery & Equipment, where positive operating margins are typical. Gross profit of CAD 573,090 suggests some pricing power, but insufficient to offset SG&A and R&D expenses. The negative ROIC and ROE indicate that capital is not being deployed effectively to generate returns. Revenue is concentrated in a single product line (wearable frequency emitters) with no disclosed geographic diversification, exposing the company to product-specific demand risks. No segment data is available, but the lack of geographic breakdown implies potential overreliance on the Canadian market or a small set of international markets. The company's outlook for the current fiscal year shows no revenue growth, with operating losses expected to persist. No forward-looking guidance is provided for the next fiscal year, but the absence of capital expenditures and negative cash flows suggest limited growth initiatives. The company's ability to scale will depend on product adoption and potential partnerships. The risk assessment highlights liquidity as a medium concern, with negative net cash after subtracting total debt. Dilution risk is currently low, but the company's negative free cash flow and CAD 485,000 in long-term debt suggest potential future financing needs. No dilution adjustments are recorded in the valuation snapshot, but the company's capital structure may require equity raises in the near term. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. However, the company's focus on wellness and performance enhancement aligns with growing consumer interest in wearable health technologies, though regulatory scrutiny in this space remains a potential risk.